Neonatal Hyperbilirubinemia (Jaundice)

AAP 2022 Risk Assessment for Neurotoxicity

• Unconjugated (indirect) bilirubin crosses the blood-brain barrier causing completely irreversible apoptosis of the basal ganglia (Kernicterus).
• Risk factors explicitly lowering the threshold for treatment: Gestational age < 38 weeks, Albumin < 3.0 g/dL, Isoimmune Hemolytic Disease (+ DAT/Coombs), G6PD deficiency.
• Clinical instability risk factors: Documented sepsis, asphyxia, significant lethargy, or temperature instability in the prior 24 hours.
• Total Serum Bilirubin (TSB) > 25 mg/dL is an absolute medical emergency (extreme risk of acute bilirubin encephalopathy).

Rigorous Screening & Diagnostics

• Visual/Clinical jaundice is fundamentally inaccurate. Universal screening via Transcutaneous Bilirubin (TcB) or TSB required between 24-48 hours.
• If TcB is >= 15 mg/dL, OR within 3 mg/dL of the phototherapy threshold, a stat venous/capillary TSB MUST be drawn.
• Direct/Conjugated hyperbilirubinemia defined as Direct Bili > 1.0 mg/dL if TSB < 5.0, or > 20% of TSB. (This indicates liver/biliary pathology, e.g., biliary atresia; phototherapy is NOT effective).
• Draw comprehensive hemolyis labs if TSB is rapidly rising (> 0.2 mg/dL/hr): Blood type, DAT, Complete Blood Count, Reticulocyte count, Peripheral blood smear.

Intensive Phototherapy Execution

• Map precise TSB + Infant age in exact hours + Gestational age onto the revised AAP 2022 Phototherapy Nomogram.
• Ensure maximum clinical irradiance: Blue-green spectrum (460-490 nm). Radiometer must strictly measure irradiance >= 30 µW/cm²/nm at the center of the infant.
• Maximize exposed Target Body Surface Area: Provide simply diaper and eye protection. Combine overhead bank lights with a biliblanket underneath.
• Discontinue phototherapy when TSB falls at least 2 mg/dL BELOW the threshold. Follow-up rebound blood draw generally required 12-24 hours later if < 7 days of age.

Intravenous Immunoglobulin (IVIG) & Exchange Transfusion

• IVIG (0.5 to 1.0 g/kg over 2 hours): Administer if TSB is aggressively approaching the exchange threshold despite maximum intensive phototherapy AND there is profound isoimmune hemolytic disease (Rh/ABO incompatibility).
• Double-Volume Exchange Transfusion (DVET): Indicated if TSB exceeds specific exact nomogram criteria, OR if infant displays any neurologic signs of acute bilirubin encephalopathy (hypertonia, arching/retrocollis, high-pitched cry).
• Prepare exactly 2 x Estimated Blood Volume (160 mL/kg) of reconstituted whole blood (O-negative PRBCs mixed with AB-plasma). Must be cross-matched to maternal serum.

Diagnostic & Management Algorithm

• Severe Jaundice Phototherapy Algorithm: [START] TSB > Phototherapy Threshold (Bhutani Nomogram) -> [ACTION] Intensive Phototherapy -> [EVALUATE] TSB falling? -> [NO] Check for hemolysis / consider IVIG -> [YES] Wean phototherapy

References

1. Kemper AR, Newman TB, Slaughter JL, et al. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics (2022 update).
2. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia. Pediatrics.